Fresh Tracks Therapeutics Inc.
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Fresh Tracks Therapeutics Inc. (FRTX) - Total Liabilities
Latest total liabilities as of December 2023: $1.66 Million USD
Based on the latest financial reports, Fresh Tracks Therapeutics Inc. (FRTX) has total liabilities worth $1.66 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fresh Tracks Therapeutics Inc. - Total Liabilities Trend (1990–2023)
This chart illustrates how Fresh Tracks Therapeutics Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Fresh Tracks Therapeutics Inc. Competitors by Total Liabilities
The table below lists competitors of Fresh Tracks Therapeutics Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fiducial Office Solutions
PA:SACI
|
France | €57.43 Million |
|
ROPER TECHNOLOGIES (ROP.SG)
STU:ROP
|
Germany | €13.04 Billion |
|
Asian Citrus Holdings Limited
PINK:ACITF
|
USA | $33.77 Million |
|
CIENA (CIE1.SG)
STU:CIE1
|
Germany | €2.68 Billion |
|
STRYKER
BE:SYK
|
Germany | €23.68 Billion |
|
ImagineAR Inc
OTCQB:IPNFF
|
USA | $3.53 Million |
|
Bangun Karya Perkasa Jaya
JK:KRYA
|
Indonesia | Rp99.50 Billion |
Liability Composition Analysis (1990–2023)
This chart breaks down Fresh Tracks Therapeutics Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fresh Tracks Therapeutics Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fresh Tracks Therapeutics Inc. (1990–2023)
The table below shows the annual total liabilities of Fresh Tracks Therapeutics Inc. from 1990 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.66 Million | -46.18% |
| 2022-12-31 | $3.08 Million | -36.03% |
| 2021-12-31 | $4.81 Million | -25.99% |
| 2020-12-31 | $6.50 Million | -38.51% |
| 2019-12-31 | $10.57 Million | +195.17% |
| 2018-12-31 | $3.58 Million | -78.83% |
| 2017-12-31 | $16.92 Million | +136.77% |
| 2016-12-31 | $7.14 Million | +58.04% |
| 2015-12-31 | $4.52 Million | -25.36% |
| 2014-12-31 | $6.06 Million | +22.59% |
| 2013-12-31 | $4.94 Million | -33.55% |
| 2012-12-31 | $7.44 Million | -11.74% |
| 2011-12-31 | $8.43 Million | -1.40% |
| 2010-12-31 | $8.54 Million | -31.03% |
| 2009-12-31 | $12.39 Million | +18.64% |
| 2008-12-31 | $10.44 Million | -2.15% |
| 2007-12-31 | $10.67 Million | -4.07% |
| 2006-12-31 | $11.13 Million | -21.78% |
| 2005-12-31 | $14.22 Million | -22.35% |
| 2004-12-31 | $18.32 Million | -12.30% |
| 2003-12-31 | $20.88 Million | +38.14% |
| 2002-12-31 | $15.12 Million | +22.56% |
| 2001-12-31 | $12.34 Million | +1.87% |
| 2000-12-31 | $12.11 Million | +89.20% |
| 1999-12-31 | $6.40 Million | +60.00% |
| 1998-12-31 | $4.00 Million | +14.29% |
| 1997-12-31 | $3.50 Million | -12.50% |
| 1996-12-31 | $4.00 Million | +122.22% |
| 1995-12-31 | $1.80 Million | -25.00% |
| 1994-12-31 | $2.40 Million | -11.11% |
| 1993-12-31 | $2.70 Million | -20.59% |
| 1992-12-31 | $3.40 Million | +112.50% |
| 1991-12-31 | $1.60 Million | +33.33% |
| 1990-12-31 | $1.20 Million | -- |